Position in VERA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$120,124,781
+$105,289,569 QoQ
Shares Held
2,799,459
+659.2% QoQ
Ownership
3.88%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 217 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,846,799 across 523 Biotechnology names. VERA ranks #29 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in VERA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,124,781 | 2,799,459 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $14,835,212 | 368,760 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,303,032 | 499,665 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $7,977,634 | 274,523 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $52,733,213 | 2,238,252 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $10,585,347 | 440,689 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,892,894 | 328,515 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $15,075,554 | 341,076 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $11,050,742 | 305,438 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $66,266,382 | 1,536,790 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $15,300,636 | 994,840 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $12,541,164 | 914,746 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $15,537,119 | 968,045 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $315,581 | 40,668 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $300,947 | 15,553 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $489,275 | 22,960 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $47,157 | 3,465 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $434,986 | 18,518 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $713,181 | 26,691 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $381,803 | 22,006 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $23,655 | 1,784 | Shares | Defined | 2021-08-23 | |
| No filing history on record for this holder in this stock. | ||||||